LTR PHARMA LIMITED - Announcements

Market Cap $150.0M Add to my watchlist

LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The... LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on holistically improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction (ED). Its lead product SPONTAN is set apart from existing ED therapies by its mechanism of action-intranasal delivery technology of a PDE5 inhibitor. The nasal cavity is a highly vascular part of the body supporting even and rapid absorption of the drug, empowering it to work in 10 minutes or less. SPONTAN (SDS-089) is a novel intranasal drug (PDE5) delivery platform for Erectile Dysfunction. More

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

No announcements returned.

REFRESH

(20min delay)
Last $1.25		Change 0.035(2.88%)		Mkt cap ! $150.0M

Open	High	Low	Value	Volume
$1.23	$1.26	$1.23	$43.34K	34.69K

Buyers (Bids)

No.	Vol.	Price($)
2	7757	$1.24

Sellers (Offers)

Price($)	Vol.	No.
$1.25	721	1

View Market Depth

No.	Vol.	Price($)
1	1246	1.605
1	625	1.600
1	1257	1.590
2	12954	1.575
1	2954	1.565

Price($)	Vol.	No.
1.615	2872	2
1.620	2954	1
1.630	5683	2
1.640	273	1
1.650	5606	2

Last trade - 10.34am 25/11/2024 (20 minute delay)


Last $1.24		Change 0.035 ( 1.63 %)
Open	High	Low	Volume
$1.25	$1.25	$1.24	3629
Last updated 10.40am 25/11/2024 ?

LTP (ASX) Chart